Novo Integrated Sciences (NVOS) has shared an announcement.
Novo Integrated Sciences, Inc. has announced that its Board of Directors approved an increase in the company’s stock repurchase program from $5 million to $10 million. The repurchase of shares will be executed as market conditions allow, utilizing excess funds potentially available from a Standby Letter of Credit related to an acquisition. The management retains the flexibility to determine the specifics of the repurchase strategy, which is not bound by any obligation to purchase a certain number of shares and can be adjusted or halted at their discretion.
Learn more about NVOS stock on TipRanks’ Stock Analysis page.
